MNDFX
Price
$8.76
Change
-$0.04 (-0.45%)
Updated
Sep 5 closing price
Net Assets
148.41M
VIVIX
Price
$71.19
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

MNDFX vs VIVIX

Header iconMNDFX vs VIVIX Comparison
Open Charts MNDFX vs VIVIXBanner chart's image
Manning & Napier Disciplined Value I
Price$8.76
Change-$0.04 (-0.45%)
VolumeN/A
Net Assets148.41M
Vanguard Value Index I
Price$71.19
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
MNDFX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MNDFX vs. VIVIX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNDFX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. MNDFX (148M). VIVIX (2.11) and MNDFX (2.02) have matching dividends . MNDFX was incepted earlier than VIVIX: MNDFX (17 years) vs VIVIX (27 years). MNDFX (0.55) is less costly to investors than VIVIX (0.04). MNDFX is a more actively managed with annual turnover of: 58.00 vs. VIVIX (9.00). MNDFX has a lower initial minimum investment than VIVIX: MNDFX (1000000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.74 vs. MNDFX (1.42). VIVIX return over 5 years is better than : 70.16 vs. MNDFX (30.19).
MNDFXVIVIXMNDFX / VIVIX
Total Expense Ratio0.550.041,375%
Annual Report Gross Expense Ratio0.550.041,375%
Fund Existence17 years27 years-
Gain YTD8.7227.866111%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets148M203B0%
Annual Yield % from dividends2.022.1196%
Returns for 1 year1.427.7418%
Returns for 3 years12.8836.6135%
Returns for 5 years30.1970.1643%
Returns for 10 years25.33131.6119%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.820.01
+1.85%
XORTX Therapeutics
CPT111.361.02
+0.92%
Camden Property Trust
TMCI7.17N/A
N/A
Treace Medical Concepts
AGIO36.01-0.12
-0.33%
Agios Pharmaceuticals
ZENV1.51-0.05
-3.21%
Zenvia